| Gerald M Woods, MD | |
|
2401 Gillham Rd, Kansas City, MO 64108-4619 | |
| (816) 234-3265 | |
| Not Available |
| Full Name | Gerald M Woods |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 2401 Gillham Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003866856 | NPI | - | NPPES |
| 201904406 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | R1D53 (Missouri) | Primary |
| Entity Name | The Childrens Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851437719 PECOS PAC ID: 2466366026 Enrollment ID: O20031118000182 |
News Archive
Chemotherapy can induce changes in the brain that may affect concentration and memory, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta - the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer's disease.
Neurodegeneration in ALS/FTD may be caused by TDP-43 aggregation in the cytoplasm, causing cellular traffic jams. The trial drug can sequester TDP-43.
Salk Professor Reuben Shaw has received the National Cancer Institute Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk's Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work.
D-Pharm Ltd., announced today that the Korean Food & Drug Administration (KFDA) approved the Investigational New Drug application for the Phase III MACSI study of DP-b99 in Korea. The IND has been submitted by D-Pharm's co-development partner in South Korea, Yungjin Pharmaceutical Company Ltd..
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gerald M Woods, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3000 | Gerald M Woods, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3265 |
News Archive
Chemotherapy can induce changes in the brain that may affect concentration and memory, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta - the protein that forms globs of plaques in the brain and which contributes to neuronal damage and the cognitive impairment associated with Alzheimer's disease.
Neurodegeneration in ALS/FTD may be caused by TDP-43 aggregation in the cytoplasm, causing cellular traffic jams. The trial drug can sequester TDP-43.
Salk Professor Reuben Shaw has received the National Cancer Institute Outstanding Investigator Award (OIA), which encourages cancer research with breakthrough potential. Shaw, a member of Salk's Molecular and Cell Biology Laboratory and holder of the William R. Brody Chair, will receive $4.2 million in direct funding over the next seven years to further his work.
D-Pharm Ltd., announced today that the Korean Food & Drug Administration (KFDA) approved the Investigational New Drug application for the Phase III MACSI study of DP-b99 in Korea. The IND has been submitted by D-Pharm's co-development partner in South Korea, Yungjin Pharmaceutical Company Ltd..
› Verified 7 days ago
Ryan A Romans, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 Fax: 816-302-9939 | |
Amanda Finn, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 8781 N Platte Purchase Dr, Kansas City, MO 64155 Phone: 816-587-3200 Fax: 816-587-7644 | |
Samira Naime, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 Fax: 816-302-9939 | |
Dr. Tess Laurynn Schultz, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 Fax: 816-302-9939 | |
Delsie Asmarah Filardi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-983-6763 Fax: 816-821-3081 | |
Dr. Gangaram Ganpatrao Akangire, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3593 |